UK Cancer Detection Firm CanSense Raises £1.5M for Development of Colorectal Cancer Test (360Dx) 0 By Praveen Suthrum on March 13, 2023 Exponential Tech Share Facebook Twitter LinkedIn Pinterest Email CanSense’s test is a blood-based assay that uses laser spectroscopy and artificial intelligence to identify early-stage colorectal cancer and precancerous polyps. Read More Artificial Intelligence Colorectal Cancer
User, expert and construct validation of a new colonoscopy simulator: correlation with National Endoscopy Database Key Performance Indicators (Science Direct)
Hackensack Meridian Jersey Shore University Medical Center Providing Novel Gastroenterology Treatments (Newswise)